The Elastin Receptor Complex: An Emerging Therapeutic Target Against Age-Related Vascular Diseases.

Tembely, Dignê et al.·Frontiers in endocrinology·2022·

Quick Facts

Study Type

Not classified

Evidence

Not graded

Sample

Not reported

What This Study Found

Key Numbers

How They Did This

Why This Research Matters

What This Study Doesn't Tell Us

Trust & Context

Original Title:: The Elastin Receptor Complex: An Emerging Therapeutic Target Against Age-Related Vascular Diseases.
Published In:: Frontiers in endocrinology, 13, 815356 (2022)
Authors:: Tembely, Dignê, Henry, Aubéri, Vanalderwiert, Laetitia, Toussaint, Kevin, Bennasroune, Amar, Blaise, Sébastien, Sartelet, Hervé, Jaisson, Stéphane, Galés, Céline, Martiny, Laurent, Duca, Laurent, Romier-Crouzet, Béatrice, Maurice, Pascal
Database ID:: RPEP-06537

Evidence Hierarchy

Meta-Analysis / Systematic Review

Randomized Controlled Trial

Cohort / Case-Control

Cross-Sectional / ObservationalSnapshot without intervening

This study

Case Report / Animal Study

What do these levels mean? →

Cite This Study

RPEP-06537·https://rethinkpeptides.com/research/RPEP-06537

APA

Tembely, Dignê; Henry, Aubéri; Vanalderwiert, Laetitia; Toussaint, Kevin; Bennasroune, Amar; Blaise, Sébastien; Sartelet, Hervé; Jaisson, Stéphane; Galés, Céline; Martiny, Laurent; Duca, Laurent; Romier-Crouzet, Béatrice; Maurice, Pascal. (2022). The Elastin Receptor Complex: An Emerging Therapeutic Target Against Age-Related Vascular Diseases.. Frontiers in endocrinology, 13, 815356. https://doi.org/10.3389/fendo.2022.815356

MLA

Tembely, Dignê, et al. "The Elastin Receptor Complex: An Emerging Therapeutic Target Against Age-Related Vascular Diseases.." Frontiers in endocrinology, 2022. https://doi.org/10.3389/fendo.2022.815356

RethinkPeptides

RethinkPeptides Research Database. "The Elastin Receptor Complex: An Emerging Therapeutic Target..." RPEP-06537. Retrieved from https://rethinkpeptides.com/research/tembely-2022-the-elastin-receptor-complex

Access the Original Study

View on PubMed View via DOI

Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.

This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.

← Back to Research Database